Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies

BACKGROUND: Bevacizumab is frequently combined with 5-fluorouracil-based chemotherapy for patients with metastatic colorectal cancer (mCRC). The relative benefit of bevacizumab in older patients has not been widely studied and is of interest. PATIENTS AND METHODS: This retrospective analysis used da...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassidy, James, Saltz, Leonard B., Giantonio, Bruce J., Kabbinavar, Fairooz F., Hurwitz, Herbert I., Rohr, Ulrich-Peter
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841755/
https://www.ncbi.nlm.nih.gov/pubmed/19904559
http://dx.doi.org/10.1007/s00432-009-0712-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841755/
https://www.ncbi.nlm.nih.gov/pubmed/19904559
http://dx.doi.org/10.1007/s00432-009-0712-3

Ejemplares similares